Skip to main content

Table 3 Tested genes that showed no or very low expression (counts < 100) in MPM patients. FANCD2 showed partially basal expression with a maximum of 214 counts

From: Gene expression profiling of homologous recombination repair pathway indicates susceptibility for olaparib treatment in malignant pleural mesothelioma in vitro

AURKA

BRCA1

CHEK2

BRIP1

FANCD2

BARD1

BRCA2

EMSY

PALB2

RAD51

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us